Pediatrix Medical (MD) Cash from Investing Activities (2009 - 2026)

Pediatrix Medical (MD) has 18 years of Cash from Investing Activities data on file, last reported at -$12.0 million in Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at -$12.0 million, down 60.49% year-over-year; the trailing twelve-month figure through Mar 2026 was -$22.8 million (up 14.35% YoY), and the FY2025 annual result was -$18.3 million, up 48.33% from the prior year.
• Cash from Investing Activities retreated to -$12.0 million in Q1 2026 per MD's latest filing, from -$10.3 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $6.6 million in Q3 2025 and troughed at -$26.3 million in Q1 2022.
• A 5-year average of -$10.0 million and a median of -$11.2 million in 2022 frame the typical range for Cash from Investing Activities.
• On a YoY basis, Cash from Investing Activities climbed as much as 252.24% in 2025 and fell as far as 430.55% in 2025.
• A 5-year view of Cash from Investing Activities shows it stood at -$11.2 million in 2022, then declined by 10.52% to -$12.4 million in 2023, then surged by 84.4% to -$1.9 million in 2024, then tumbled by 430.55% to -$10.3 million in 2025, then decreased by 16.5% to -$12.0 million in 2026.
• Business Quant data shows MD's Cash from Investing Activities at -$12.0 million in Q1 2026, -$10.3 million in Q4 2025, and $6.6 million in Q3 2025.